Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials

Author(s):
Avila, E.K.; Chamberlain, M.; Schiff, D.; Reijneveld, J.C.; Armstrong, T.S.; Ruda, R.; Wen, P.Y.; Weller, M.; Koekkoek, J.A.F.; Mittal, S.; Arakawa, Y.; Choucair, A.; Gonzalez-Martinez, J.; MacDonald, D.R.; Nishikawa, R.; Shah, A.; Vecht, C.J.; Warren, P.; Bent, M.J. van den; DeAngelis, L.M.
Published
2017
Publication type
Article / Letter to editor
gliomalow-grademetricscaleseizures
Date issued
2017-01-31
Language
English
Is part of
Neuro-Oncology (2017), Vol. 19, no. 1, p. 12-21
hdl
1887/115066
doi
10.1093/neuonc/now190